Pretreatment of Formula or Expressed Breast Milk With Sodium Polystyrene Sulfonate (Kayexalate®) as a Treatment for Hyperkalemia in Infants With Acute or Chronic Renal Insufficiency-Reference-Cited by-同舟云学术

Pretreatment of Formula or Expressed Breast Milk With Sodium Polystyrene Sulfonate (Kayexalate®) as a Treatment for Hyperkalemia in Infants With Acute or Chronic Renal Insufficiency

Published:2013-09 Issue:5 Volume:23 Page:333-339
ISSN:1051-2276
Container-title:Journal of Renal Nutrition
language:en
Short-container-title:Journal of Renal Nutrition

Author:

Thompson Kirsten,Flynn Joseph,Okamura Daryl,Zhou Li

Publisher

Elsevier BV

Subject

Nephrology,Nutrition and Dietetics,Medicine (miscellaneous)

Reference16 articles.

1. Interventions for non-oliguric hyperkalemia in preterm neonates;Vemgal;Cochrane Database Syst Rev,2007

2. Sodium polystyrene sulfonate: a cation exchange resin used in treating hyperkalemia;Meyer;ANNA J,1993

3. U.S. Food and Drug Administration: Kayexalate (sodium polystyrene sulfonate) powder. http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm186845.htm. Accessed June 1, 2012.

4. Sodium polystyrene sulfonate;Noerr;Neonatal Netw,1993

5. Complications following oral administration of exchange resins in extremely low-birth-weight infants;Ohlsson;Eur J Pediatr,1987

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and predictors of acute kidney injury among asphyxiated neonates in comprehensive specialized hospitals, northwest Ethiopia, 2023;Scientific Reports;2024-07-17

2. Chronic Kidney Disease;Avery's Diseases of the Newborn;2024

3. Acute Kidney Injury;Avery's Diseases of the Newborn;2024

4. Incidence of Acute Kidney Injury and its predictors among neonates admitted at neonatal intensive care unit, university of Gondar, Debretabor and Tibebe Ghion Amhara Region Comprehensive Specialized Hospitals, Northwest Ethiopia, 2023;2023-06-01

5. A case of 1-month-old female infant delaying peritoneal dialysis introduction by low-potassium anti-allergic formula treated with sodium polystyrene sulfonate;CEN Case Reports;2022-04-20